We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Purdue Files Suits Against Impax, Epic as it Continues Efforts to Ward Off OxyContin Generics
Purdue Files Suits Against Impax, Epic as it Continues Efforts to Ward Off OxyContin Generics
February 4, 2013
Purdue Pharma is suing Impax Laboratories and Epic Pharma, aiming to prevent the drugmakers from launching generics of its blockbuster painkiller OxyContin before three patents expire in 2025.